Public case information

Nektar Therapeutics Securities Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Nektar Therapeutics · Nektar Therapeutics securities · Ongoing Litigation

Last updated

About this case

A securities class action has been filed against Nektar Therapeutics on behalf of investors who purchased or acquired Nektar securities from February 26, 2025, through December 15, 2025. The specific alleged conduct is not stated; the matter was filed, and the lead-plaintiff application deadline was May 5, 2026.

Case overview

Defendant company
Nektar Therapeutics
Product or service
Nektar Therapeutics securities
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Other

Important dates

Lead plaintiff application

Participation information

Availability is based on each listed participation option and its deadline.

Lead plaintiff application

Investors who purchased or acquired Nektar securities between February 26, 2025, and December 15, 2025, could apply to the court to be appointed lead plaintiff before the stated deadline.

Apply to the court to be appointed lead plaintiff by May 5, 2026.

Type
Lead Plaintiff
Status
Deadline passed

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.